基础医学与临床 ›› 2026, Vol. 46 ›› Issue (11): 1483-1490.doi: 10.16352/j.issn.1001-6325.2026.11.1483

• 研究论文 • 上一篇    下一篇

Nrf1减轻高脂诱导的小鼠心肌细胞系HL-1铁死亡

宋志平1, 侯兴志1, 黎俊雅2, 李福祥2, 黄波3*, 冯健2*   

  1. 1.岳池县人民医院 心内科,四川 广安 638300;
    中国人民解放军西部战区总医院 2.重症医学科;3.烧伤整形科,四川 成都 610083
  • 收稿日期:2025-09-07 修回日期:2025-12-30 出版日期:2026-11-05 发布日期:2026-10-26
  • 通讯作者: *ironvon@foxmail.com;865072374@qq.com
  • 基金资助:
    四川省科研计划(2023年)

Nrf1 alleviates high-fat-induced ferroptosis of murine cardiomyocyte cell line HL-1

SONG Zhiping1, HOU Xingzhi1, LI Junya2, LI Fuxiang2, HUANG Bo3*, FENG Jian2*   

  1. 1. Department of Cardiology, the People′s Hospital of Yuechi County, Guang′an 638300;
    2. Department of Critical Care Medicine; 3. Department of Burns and Plastic Surgery, the General Hospital of Western Theater Command of Chinese PLA, Chengdu 610083, China
  • Received:2025-09-07 Revised:2025-12-30 Online:2026-11-05 Published:2026-10-26
  • Contact: *ironvon@foxmail.com;865072374@qq.com

摘要: 目的 探讨核因子红系2相关因子1(Nrf1)在高脂(HF)诱导的小鼠心肌细胞系HL-1铁死亡中的作用及其机制。方法 将HL-1细胞分别给予0、100、200、300、400和500 μmol/L棕榈酸(PA)干预24 h构建高脂模型,最终选取300 μmol/L棕榈酸作为后续高脂干预浓度。分为对照组(control)、vehicle组(HF+溶剂)、ferrostatin-1组(HF+铁死亡抑制剂)、叔丁基对苯二酚(tBHQ)组(HF+Nrf1 激动剂)、Erastin组(HF+铁死亡激动剂)、tBHQ + Erastin组(HF + Nrf1激动剂+铁死亡激动剂)。CCK-8法测定HL-1细胞活力,DCFH-DA荧光探针法对HL-1细胞中活性氧(ROS)含量进行测定,MDA试剂盒测定丙二醛(MDA) 浓度,谷胱甘肽(GSH)试剂盒测定GSH 浓度,谷胱甘肽过氧化物酶 4(GPX4)试剂盒测定GPX4浓度;RT-qPCR及Western blot检测铁死亡标志物前列腺素内过氧化物合酶2(PTGS2)及Nrf1表达水平。结果 随着棕榈酸浓度的升高,HL-1细胞活力明显降低,且300 μmol/L棕榈酸干预后,HL-1细胞活力较对照组显著降低(P<0.001);高脂条件下心肌铁死亡标志物PTGS2水平显著升高,GSH、GPX4水平显著降低(P<0.05或 P<0.01);相反使用铁死亡特异性抑制剂Ferrostatin-1后,细胞活力显著改善(P<0.01),高脂诱导的铁死亡被明显减轻(P<0.05)。高脂组Nrf1表达(mRNA及蛋白质水平)明显降低(P<0.01);在此基础上使用Nrf1激动剂(tBHQ)后,细胞活力明显增加(P<0.01),铁死亡程度明显降低(P<0.01)。使用铁死亡激动剂Erastin,能够降低Nrf1激动剂的心肌保护作用(P<0.05)。结论 Nrf1可通过抑制铁死亡途径,发挥高脂环境下的HL-1细胞保护作用,有望成为高脂性心肌损伤的潜在干预靶点。

关键词: 小鼠心肌细胞系HL-1, 高脂, 铁死亡, 核因子红系2相关因子1(Nrf1)

Abstract: Objective To investigate the effect of nuclear factor-erythroid 2-related factor 1(Nrf1) on ferroptosis of murine cardiomyocyte cell line HL-1 induced by high-fat (HF) and its underlying mechanism. Methods HL-1 cells were incubated with different doses of 0 palmitic acid(PA) as 100, 200, 300, 400, and 500 μmol/L PA for 24 hours, and 300 μmol/L PA acid was selected as the subsequent HF intervention concentration. The cells were divided into the following groups: control group, vehicle group (HF + solvent), ferrostatin-1 group (HF+ferroptosis inhibitor), tert-butylhydroquinone (tBHQ) group (HF+Nrf1 agonist), Erastin group (HF+ferroptosisagonist), and tBHQ+Erastin group (HF + Nrf1 agonist + ferroptosis agonist). Cell viability of HL-1 cells was determined by the CCK-8 assay. Intracellular reactive oxygen species (ROS) level was measured by DCFH-DA fluorescent probe assay. The concentration of malondialdehyde(MDA),glutathione(GSH),and glutathione peroxidase 4(GPX4)was determined by commercial available kits. The expression level of ferroptosis marker prostaglandin-endoperoxide synthase 2(PTGS2) and Nrf1 was detected by RT-qPCR and Western blot. Results With the increase of palmitic acid concentration, the viability of HL-1 cells decreased significantly, and after intervention with 300 μmol/L PA, the viability of HL-1 cells was significantly lower than that of the control group(P<0.001). Under high-fat conditions, the level of myocardial ferroptosis marker PTGS2 increased significantly, while the level of GSH and GPX4 decreased significantly(all P<0.05 or P<0.01). On the contrary, after incubation with ferrostatin-1, a specific inhibitor of ferroptosis, cell viability was significantly improved(P<0.01), and high-fat-induced ferroptosis was significantly reversed(P<0.05). At the same time, the expression of Nrf1(both mRNA and protein levels) in high-fat group was significantly decreased(P<0.01). After adding Nrf1 agonist(tBHQ), cell viability increased significantly(P<0.01), and the degree of ferroptosis decreased significantly(P<0.01). Further use of the ferroptosis agonist Erastin reversed the myocardial protective effect of Nrf1 agonist(P<0.05). Conclusions High-fat can aggravate ferroptosis of cardiomyocytes by causing oxidative stress and reducing antioxidant capacity. Nrf1 can play a myocardial protective role in high-fat environment by inhibition of ferroptosis.

Key words: mouse cardiomyocyte cell line HL-1, high-fat, ferroptosis, nuclear factor-erythroid 2-related factor 1(Nrf1)

中图分类号: